Oculis Holding AG Ordinary shares

Oculis Holding AG Ordinary shares

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$7.50
Previous Close
$7.63
Day Range
$6.84-$7.70
52W Range
$7.11-$34.47
Market Cap
$469.9M
Shares Short
1M

Financials

See more
Revenue (12 Mos)
$1.1M
Revenue Growth (YoY)
18.8%
Gross Profit (12 Mos)
-$55.5M
Diluted EPS
-$1.74

News

See more

Yahoo Finance • 14 days ago

Oculis Reports New Phase 2 ACUITY Biomarker Data Further Supporting Privosegtor’s Neuroprotective Potential in Optic Neuritis

Yahoo Finance • 14 days ago

Oculis Reports New Phase 2 ACUITY Biomarker Data  Further Supporting Privosegtor’s Neuroprotective Potential in Optic Neuritis

Yahoo Finance • 3 months ago

Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company

Yahoo Finance • 3 months ago

Oculis undirritar kaupsamning við Accure Therapeutics um leiðandi þróunarlyfið Privosegtor og eflir þannig stöðu Oculis sem leiðandi vaxtarfyrirtækis á sviði taugaaugnlækninga

About

CEO
Dr. Riad Sherif M.B.A., M.D.
Address
Bahnhofstrasse 20, Zug, Switzerland, 6300
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
60